Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Tokyo Big Sight

Nov 10, 2019 9:30 AM - Nov 12, 2019 5:40 PM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

16th DIA Japan Annual Meeting 2019

Delivering Rational Medicine for All People in the Globe

[S42] Think About Informed Consent from a Patient’s Perspective – What Can We Do to Promote Proper Understanding of Clinical Trials and PatientFriendly Clinical Trials?

Session Chair(s)

Kazuo  Hasegawa

Kazuo Hasegawa

Representative Director

OnestepLung Cancer Patient Network ONE STEP, Japan

Informed consent is the first important process for patients to learn about and understand clinical trials. Recently, volume and complexity of Informed consent documents are increasing. In this session, we will discuss how we can improve informed consent documents and communication from a patient’s perspective based on the recent efforts in Japan and global.


David P. Leventhal, MBA

Bringing Patient Centricity to Informed Consent and Promoting Understanding of Clinical Research Participation

David P. Leventhal, MBA

Pfizer Inc, United States

Enterprise Clinical Trial Data Sharing Lead, Global Data Dissemination

Yumiko  Miyazaki, MSc

How Do We Make “Easy-to-Understand ICF” Come True?

Yumiko Miyazaki, MSc

Eli Lilly Japan K.K., Japan

Manager, Clinical Innovations & Business Integration,

Yukari  Suzuki, RN

From the Standpoint of CRC That Uses Various ICFs and Supports Many Subjects

Yukari Suzuki, RN

Nigata University Medical and Dental Hospital, Japan

Chief Clinical Research Coordinator, Clinical and Translational Research Center

Shinsuke  Amano

Shinsuke Amano

Group Nexus Japan, Japan


Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.